Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity
ACS Pharmacology & Translational Science · 09.02.2024 · 7 (2) · 493-514
DOI: 10.1021/acsptsci.3c00313 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 19.01.2024. Verfasst von Philipp Flury und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Auf de…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, Tübingen 72076, Germany.
- PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, Bonn 53121, Germany.
- Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research Göttingen, Kellnerweg 4, Göttingen 37077, Germany.
- Faculty of Biology and Psychology, University Göttingen, Göttingen 37073, Germany.
- Faculty of Health Sciences, School of Pharmacy, University of Eastern Finland, Kuopio 70211, Finland.
- Excellence Cluster "Controlling Microbes to Fight Infections" (CMFI), Tübingen 72076, Germany.
ORCID-Profile: Antti Poso, Stefan A Laufer, Christa E Müller, Michael Gütschow, Thanigaimalai Pillaiyar
Zitieren
APA
Flury, P., Breidenbach, J., Krüger, N., Voget, R., Schäkel, L., Si, Y., Krasniqi, V., Calistri, S., Olfert, M., Sylvester, K., Rocha, C., Ditzinger, R., Rasch, A., Pöhlmann, S., Kronenberger, T., Poso, A., Rox, K., Laufer, S. A., Müller, C. E., …, & Pillaiyar, T. (2024). Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity. ACS Pharmacology & Translational Science, 7(2), 493-514. https://doi.org/10.1021/acsptsci.3c00313
Vancouver
Flury P, Breidenbach J, Krüger N, Voget R, Schäkel L, Si Y, et al. Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity. ACS Pharmacology & Translational Science. 2024;7(2):493-514. doi:10.1021/acsptsci.3c00313
BibTeX
@article{Flury2024,
author = {Flury, Philipp and Breidenbach, Julian and Krüger, Nadine and Voget, Rabea and Schäkel, Laura and Si, Yaoyao and Krasniqi, Vesa and Calistri, Sara and Olfert, Matthias and Sylvester, Katharina and Rocha, Cheila and Ditzinger, Raphael and Rasch, Alexander and Pöhlmann, Stefan and Kronenberger, Thales and Poso, Antti and Rox, Katharina and Laufer, Stefan A and Müller, Christa E and Gütschow, Michael and Pillaiyar, Thanigaimalai},
title = {Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity},
journal = {ACS Pharmacology & Translational Science},
year = {2024},
volume = {7},
number = {2},
pages = {493--514},
doi = {10.1021/acsptsci.3c00313}
}
EUVIMED